Anti-™EM132D monoclonal antibody

Pre-made anti-™EM132D monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM132D/™EM132D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1977-Ab-1/ GM-Tg-hg-IP1977-Ab-2Anti-Human ™EM132D monoclonal antibodyHuman
GM-Tg-rg-IP1977-Ab-1/ GM-Tg-rg-IP1977-Ab-2Anti-Rat ™EM132D monoclonal antibodyRat
GM-Tg-mg-IP1977-Ab-1/ GM-Tg-mg-IP1977-Ab-2Anti-Mouse ™EM132D monoclonal antibodyMouse
GM-Tg-cynog-IP1977-Ab-1/ GM-Tg-cynog-IP1977-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM132D monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1977-Ab-1/ GM-Tg-felg-IP1977-Ab-2Anti-Feline ™EM132D monoclonal antibodyFeline
GM-Tg-cang-IP1977-Ab-1/ GM-Tg-cang-IP1977-Ab-2Anti-Canine ™EM132D monoclonal antibodyCanine
GM-Tg-bovg-IP1977-Ab-1/ GM-Tg-bovg-IP1977-Ab-2Anti-Bovine ™EM132D monoclonal antibodyBovine
GM-Tg-equg-IP1977-Ab-1/ GM-Tg-equg-IP1977-Ab-2Anti-Equine ™EM132D monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1977-Ab-1/ GM-Tg-hg-IP1977-Ab-2; GM-Tg-rg-IP1977-Ab-1/ GM-Tg-rg-IP1977-Ab-2;
GM-Tg-mg-IP1977-Ab-1/ GM-Tg-mg-IP1977-Ab-2; GM-Tg-cynog-IP1977-Ab-1/ GM-Tg-cynog-IP1977-Ab-2;
GM-Tg-felg-IP1977-Ab-1/ GM-Tg-felg-IP1977-Ab-2; GM-Tg-cang-IP1977-Ab-1/ GM-Tg-cang-IP1977-Ab-2;
GM-Tg-bovg-IP1977-Ab-1/ GM-Tg-bovg-IP1977-Ab-2; GM-Tg-equg-IP1977-Ab-1/ GM-Tg-equg-IP1977-Ab-2
Products NameAnti-™EM132D monoclonal antibody
Formatmab
Target Name™EM132D
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM132D monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1977-Ag-1Recombinant multi-species T132D/ ™EM132D/ MOLT protein


    Target information

    Target IDGM-IP1977
    Target Name™EM132D
    Gene ID121256,243274,288750,716854,486233,101081417,100297935,100147694
    Gene Symbol and SynonymsC630028F04Rik,MOLT,PPP1R153,™EM132D
    Uniprot AccessionQ14C87,Q76HP2
    Uniprot Entry NameT132D_HUMAN,T132D_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000151952
    Target ClassificationN/A

    The target: ™EM132D, gene name: ™EM132D, also named as MOLT, PPP1R153. .



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.